An observational study in Dyspnea,, Acute Heart Failure Syndrome and Pulmonary Congestion, sponsored by Intersection Medical, Inc.. Completed at 2 sites in United States. Open to participants aged 45 Years and older. Per ClinicalTrials.gov, last updated 2015-10-14.
Sponsored by Intersection Medical, Inc. · Observational
The purpose of this study is to determine the distribution of lung fluid status as reported by the IMED-4 system in patients presenting to the emergency department or urgent care facility with shortness of breath.
656 studies on the registry are indexed under Dyspnea; 153 are open to participants now.
This study's enrollment of 156 is above the median of 122 across 204 observational studies indexed under Dyspnea.
Browse Dyspnea studies →Intersection Medical, Inc. is the lead sponsor of 4 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients who present with shortness of breath to an emergency department or urgent care facility are possible candidates for the study and shall be screened for suitability based on the inclusion and exclusion criteria.
EXCLUSION CRITERIA
Lung Fluid Status
The IMED 4 is a new device designed to measure the lung fluid status by assessing how wet or dry the lungs are
Time frame: Up to 1 year
This study is completed, as verified in Oct 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Intersection Medical, Inc.